Tag: SK bioscience

Global Phase 1b Trial Advances New RSV Preventive Antibody

SK bioscience submits a global Phase 1b CTA for RSM01, an RSV…

ME Desk

Sanofi begins Phase 3 trials for PCV21, expands SK Bioscience partnership

Paris- 23 December 2024- Sanofi and SK bioscience have entered into a…

ME Desk